logo
Scientists pinpoint reason why more boys than girls have autism and ADHD

Scientists pinpoint reason why more boys than girls have autism and ADHD

Daily Mail​2 days ago
It's a question that has long stumped researchers.
Now, new light has been shed on one reason why three times more boys than girls are diagnosed with autism and ADHD.
Researchers from the University of Rochester have suggested that boys may be more vulnerable to environmental stressors such as toxic 'forever chemicals' as their brain develops.
These chemicals are believed to warp brain signals, causing long-term behavioral changes in boys, such as social anxiety, difficulty sitting still and finding it hard to follow instructions.
Found in everything from plastic bottles, clothing and even drinking water, these chemicals can take thousands of years to degrade and have been linked to cancer, infertility and birth defects.
In the current study, the scientists pinpointed a specific 'forever chemical' known as PFHxA, which is used in paper food packaging and stain-resistant fabrics.
Researchers say it could cause anxiety-like behaviours seen in autism and ADHD, but oddly, mostly in boys.
They conducted a study that involved exposing baby mice to the toxin via their mother's milk.
The scientists found that the male baby mice showed alarming developmental changes including a decrease in activity levels, increased anxiety and memory problems.
Significantly, researchers did not observe the same behaviour changes in the female baby mice.
Even years after the mice had first been exposed to the chemical, they still showed behavioral patterns associated with the disorders, suggesting forever chemical exposure could have long-lasting effects on the brain.
Professor Elizabeth Plunk, first author of the study and expert in environmental medicine desribed the findings as 'concerning'.
Writing in the European Journal of Neuroscience, researchers said: 'Although these effects were mild, finding behavioral effects only in males was reminiscent of many neurodevelopmental disorders that are male-biased.'
'Understanding the impact of PFHxA on the developing brain is critical when proposing regulations around this chemical,' Prof Plunk added.
The researchers hope that this will be the first of many studies investigating the harmful effects of PFHxA on the brain—with a renewed focus on the areas of the brain responsible for movement, memory and emotions.
The findings come amid rising concerns over a surge in ADHD diagnoses —with an estimated 2.5million people in England now living with the attention deficit disorder, according to the NHS.
ADHD is a neurodevelopmental disorder that affects concentration, impulse control and activity levels.
Common symptoms include restlessness, distractibility, forgetfulness, difficulty following instructions or managing time, and making impulsive decisions.
Similarly, officials have warned that the NHS is 'overwhelmed' by soaring autism rates as 200,000 people wait for an autism assessment in England according to the latest figures.
Autism is a spectrum disorder which affects how people communicate and interact.
According to the World Health Organisation, around one in 100 children across the globe have the condition.
Autistic children may avoid eye contact and not respond to their name being called, among other symptoms.
Autism is not a disease and people have it from the moment they are born, although it may not be spotted until childhood and sometimes much later.
Researchers are now worried that forever chemicals could be contributing to the surge in cases, with experts warning earlier this year the the UK's regulation of the toxic element is too lax.
PFAS are found in hundreds of everyday products due to their durability.
But last year a review of 500 studies found they were linked to 'serious health implications', including weakening the immune system and being a factor in cancer diagnosis.
Now the Environmental Audit Committee (EAC) is set to put recommendations to the Government by the end of the year on whether the UK needs to introduce stricter guidelines.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Patients with ultra-rare diseases worry new FDA rules will leave them without treatment
Patients with ultra-rare diseases worry new FDA rules will leave them without treatment

The Guardian

time30 minutes ago

  • The Guardian

Patients with ultra-rare diseases worry new FDA rules will leave them without treatment

US drug regulators have increasingly signaled a focus on faster approvals and rare diseases, but patients with ultra-rare ailments fear they are falling through the cracks, especially given challenges to conducting clinical trials. One drug, elamipretide, garnered a narrow recommendation from independent advisers for the US Food and Drug Administration (FDA), but the agency rejected the drug's application in May and recommended another potential pathway for approval. Patients and advocates worry about new rules on who may receive the medication during this process, and whether the drug will reach approval before the pharmaceutical company runs out of funding for it. It underscores the challenges of making progress on rare and ultra-rare diseases while also making sure treatments are safe and effective. Hope Filchak is a sassy four-and-a-half-year-old who loves swimming in the lakes and pools near her home in Gainesville, Georgia. She's also deaf and blind, with some functional vision in one eye and hearing with an aid in one ear. Hope was born with an extremely rare mitochondrial condition called MLS syndrome, of which there were only 64 documented cases in the US as of 2018. MLS syndrome, for Hope, causes a potentially life-threatening heart condition called cardiomyopathy, which can make her heart pump blood less efficiently. In February 2024, she started sleeping about 17 hours a day, and her speech began regressing. An echocardiogram revealed that Hope's heart function had dropped about 14 percentage points, into potentially hazardous territory. She then started taking elamipretide, an investigational drug for mitochondrial conditions. 'Pretty soon, honestly, she had a lot more energy,' her mother, Caroline Filchak, said. Most importantly, her heart stabilized. Hope's aunt, Anna Bower, said her niece's 'quality of life dramatically improved' and soon after, she was 'running, dancing, and playing' like any other child her age. First developed in 2004, elamipretide has a long history. Advocates for patients with Barth syndrome – another mitochondrial condition with about 150 known patients – asked Stealth BioTherapeutics to pick up the drug in 2014 and shepherd it through the regulatory process. Stealth submitted its first application to the FDA in 2019, and then it went through four different review divisions at the agency. In an October 2024 meeting of the FDA's cardiovascular and renal drugs advisory committee, patients and physicians spoke about the positive effects of the drug, and the advisers eventually voted 10-6 to recommend it. 'Patients and families saw the [advisory committee's] endorsement as an encouraging sign because the FDA almost always follows its recommendation,' Bower said in June. 'But last month, it didn't.' The FDA rejected the application in May. Internal FDA reviewers noted that the drug had not met its endpoint in phase 2 trials of 12 study participants. 'We don't feel like they looked at a totality of evidence where the patient's voice was heard in the decision,' Caroline Filchak said, who added that it's been difficult to measure the effectiveness of the drug because of how rare the disease is. The FDA did offer a new pathway to approval, Stealth said in a press release. That process takes at least eight months, though it can also take years. Stealth laid off 30% of its staff after the rejection. Advocates such as Filchak are worried the company will not be able to continue pursuing approval. 'If [the FDA] drag their feet like they have throughout this entire process, Stealth is not going to be able to continue operations,' she said. Under the new pathway, the medication is not available for infants. Stealth has said that 35 patients around the world are receiving the medication, and two-thirds of them are very sick infants. In a congressional hearing in late June, the Republican representative Earl L 'Buddy' Carter of Georgia asked Robert F Kennedy Jr, the secretary of the US Department of Health and Human Services, about treatments for rare mitochondrial conditions. Carter mentioned two young constituents with these conditions, including Hope Filchak. The children 'need your help in accessing life-saving medications', Carter said, promising to follow up with Kennedy after the hearing. For now, Hope has a three-month supply of the drug. 'For children like Hope, there are no other options,' Bower said. There are no FDA-approved medications like elamipretide, and there are no similar drugs in late-stage development. Caroline Filchak said that this administration 'does have a stated commitment to accelerating therapies for rare diseases. And it seems like this recent decision by the FDA doesn't align with that commitment.' Marty Makary, the FDA's commissioner, recently announced plans to accelerate approval for select drugs and companies. He has also floated the use of machine learning, often called AI, to review applications quickly. But there are already four ways for the FDA to expedite the review of new medications, and the approval speed is not the sticking point for drugs such as these, Filchak said. Elamipretide is an example of the difficulty of developing drugs for ultra-rare conditions – and for approving them based on clinical evidence, said Holly Fernandez Lynch, bioethicist at the University of Pennsylvania Perelman School of Medicine. 'It's not the poster child of FDA efficiency,' Fernandez Lynch said, noting the long time span and the four different review divisions at FDA. 'But it's also not the poster child of 'Oh my God, we have a drug that works amazingly well, and FDA is standing in the way, and why won't they just use their regulatory flexibility?'' The drug hasn't been approved yet because it hasn't met a pre-specified endpoint, Fernandez Lynch added: 'If the evidence doesn't support approval, if the systematic evidence collection doesn't show benefit, then FDA really can't approve it.' The biotech company is now resubmitting data on knee strength improvement as part of its new application. 'Of course, these patients have a need. Of course, they have an altered tolerance for risk and altered tolerance for uncertainty,' said Fernandez Lynch. 'That's the really devastating part of all of this. And it's really heartbreaking, but it does not mean the FDA should grant approval to a product that hasn't been demonstrated effective, because we really don't know that it works.' Approving a medication without this evidence could lead to issues developing other drugs for the same conditions, Fernandez Lynch said. 'People say, 'Well, what's the big deal? These patients have nothing. Just let them try it.' I get that. If I was that mom, I would do the same thing, right? But the FDA has to make judgments for the population,' she said. For Caroline Filchak, who works for a petroleum delivery company, she plans to continue advocating for her daughter and other affected children – and has even gotten the whole family involved. 'You don't, when you think about having a kid, think that you're going to be doing this, but you do what you've got to do for your kids,' she said, noting that she and her husband, Ben, took their seven-year-old son, Thomas, to the October meeting. 'We call him our baby advocate. Ever since that meeting, every night when he would say his prayers, he would pray that the FDA says 'yes'.'

Sami Sheen grabs some food in LA after revealing plans to remove breast implants
Sami Sheen grabs some food in LA after revealing plans to remove breast implants

Daily Mail​

timean hour ago

  • Daily Mail​

Sami Sheen grabs some food in LA after revealing plans to remove breast implants

Sami Sheen enjoyed some refreshment at an Erewhon market in Calabasas, California, on Friday. The 21-year-old daughter of Denise Richards and Charlie Sheen was spotted leaving the market with a container of food. Two weeks ago the OnlyFans star revealed she plans to have her breast implants removed less than two years after she got them. She wrote that she's 'been experiencing health issues for nearly 2 years' with 'the weirdest symptoms.' Sami said that she 'finally discovered that I have breast implant illness,' adding, 'idk how I [hadn't] figured this out sooner but I'm so happy to finally have an answer.' She told her 202,000 followers: 'I'm hoping to get them removed asap so I can start feeling better.' And she asked: 'Pls lmk if you know of any good explant surgeons near LA.' Looking back at a picture of her pre-cosmetic surgery figure, Sami said; 'It's definitely gonna be hard going back to this size. not only physically, but mentally.' She lamented: 'I don't want to at all but i know i'll feel so much better once they are out. so i guess it's worth it.' She told fans: 'I posted about this on my TikTok but figured i would talk about it on here in case anyone else is experiencing the same thing. this is your sign to always put your health first!!!' The reality television star also noted that her sickness has affected her hair, writing in parentheses: 'Also I can't believe this is all my real hair, another thing that these implants took from me.' Someone asked Sheen what her symptoms are, which she detailed in a list. Chronic fatigue, headaches, acne, memory loss, brain fog, vertigo, joint pain, dry eyes, and mood swings were just some of the uncomfortable effects. Also listed were hair loss, allergies, skin rashes, severe anxiety, and sensitivity to temperature. Sami shared: 'BII often mimics certain autoimmune diseases, but I'm certain it's my implants because these symptoms started almost immediately after getting them done.' The influencer said she experiences 'nearly all of these symptoms every single day' and that 'it's exhausting'. The list goes on: Also listed were hair loss, allergies, skin rashes, severe anxiety, and sensitivity to temperature As recently as April, Sami said on TikTok that she planned to get another, larger boob job. She said at the time: 'They're finally fully dropped and settled in. I feel like I could've gone bigger and I really wish I went bigger. When the time comes to get them redone I'm definitely going bigger.' The star initially went under the knife in 2023 at age 19. 'I think I'm gonna go over the muscle so they look a little bit more natural,' she shared at the time.

Forget rosemary oil, RED ONION's the secret to stopping hair loss, Dr claims – how to use it for new growth in 6 weeks
Forget rosemary oil, RED ONION's the secret to stopping hair loss, Dr claims – how to use it for new growth in 6 weeks

The Sun

time4 hours ago

  • The Sun

Forget rosemary oil, RED ONION's the secret to stopping hair loss, Dr claims – how to use it for new growth in 6 weeks

IF you're battling with hair loss, fear not, you've come to the right place. And especially if you can't afford to break the bank on expensive shampoos and posh haircare treatments, don't worry, we've got just the thing for you. 4 A doctor has revealed the secret to combating hair loss - and you may be surprised to know that the key isn't a high-street supplement or oil. In fact, according to this pro, a red onion will help to fix your hair loss. Not only this, but it will also protect against fungus, mould and dandruff too - yes, you heard that correctly. In a recent video that was posted on YouTube, Dr Eric Berg DC claimed that red onions are "packed with sulphur," which aids the body in producing keratin, the primary protein found in hair. These pungent vegetables also boast "the highest amount of quercetin," which helps combat some of the root causes of hair loss. The health expert acknowledged: "Quercitin helps increase the growth hormones of the hair follicle. 'It is also a powerful antimicrobial, protecting your scalp from overgrowth of yeast, fungus, mould, and dandruff." The remedy involves a simple red onion as it "has the most quercetin" - but instead of eating it, Dr Berg explained how a homemade onion 'shampoo' could be an incredibly effective treatment. To prepare the solution, simply chop and blend a red onion before straining the mixture through cheesecloth to fully separate the liquid from any remaining chunks. Once the preparation is done, while in the shower, massage the onion juice through damp hair and into the roots for a few minutes. Kyle Richards' daughter Sophia, 25, reveals her hair is falling out after taking weight loss drug saying 'I'm gonna be bald!' But don't rinse it off immediately - instead, Dr Berg advised beauty fans to let the solution sit in your locks for up to an hour and 'allow it to work its magic.' Then, jump back into the shower and "shampoo your hair twice" to wash away any lingering onion smells. If the smell persists, you can add a dash of lemon juice or some rose water to your hair. Hair Loss 101 HAIR pro Samantha Cusick has revealed everything you need to know about hair loss. Why Does Hair Loss Happen? Hair loss can be influenced by so many factors, from genetics and hormone changes to lifestyle choices. Stress, diet, and even hair care habits can all impact hair strength. It's perfectly normal to lose some hair each day, but sometimes the body can shed more than usual, responding to things like hormonal shifts or even life stressors. Why It Happens More This Time of Year Have you ever noticed your hair seems to shed more in autumn? That's seasonal shedding! During summer, we hold onto extra hair to protect our scalp from the sun. As the weather cools, it's like our body recalibrates and lets go of those extra strands. Dry, cooler air can also make hair more brittle, making it easier to lose a little extra volume during these months. Hacks and Affordable Buys to Treat Hair loss The great news? You don't need to spend a fortune on pricey treatments to support your hair. Try daily scalp massages—they're so simple but really help boost blood flow to the follicles. Castor oil is another fantastic, budget-friendly option that's rich in nutrients to strengthen your strands. Adding a bit more protein to your diet and a biotin supplement can also work wonders for overall hair health. Products to Avoid Steer clear of products with high levels of alcohol, sulphates, and parabens - they can be drying and damage hair over time. Heat styling and chemical treatments can also cause breakage, so try to use them sparingly. Instead, look for gentle, hydrating formulas to support your scalp and keep hair healthier through the seasons. Backed by scientific evidence While this may seem like an online beauty fad, it has been supported by scientific evidence. Compared to tap water, people who used this raw onion juice treatment for alopecia noticed "significantly higher results with regard to hair re-growth." A small study published in the Journal of Dermatology suggested that applying onion juice to the scalp could potentially assist in hair regrowth for some. This research involved participants suffering from alopecia areata, a type of patchy, non-scarring hair loss. It is also a powerful antimicrobial, protecting your scalp from overgrowth of yeast, fungus, mould, and dandruff Dr Eric Berg DC The researchers identified that hair growth commenced after just two weeks of applying onion juice to the scalp twice daily. Not only this, but nearly 74% of the participants witnessed some hair regrowth after four weeks, and by six weeks, around 87% reported regrowth. Both men and women participated in the study, with men demonstrating a higher rate of hair regrowth. Won't break the bank And fortunately, those strapped for cash will be pleased to know that this DIY haircare remedy doesn't have to be expensive. In fact, it's super affordable and great for those on a budget, as a pack of three red onions can be purchased from Aldi for just 95p, which works out at only 32p per onion. According to Dr Berg, applying onion juice twice a week for about six weeks is sufficient to ensure hair growth. While it may take some time to notice results, most people report seeing hair growth after the third or fourth week. To enhance the onion juice treatment, Dr Berg recommended adding five drops of rosemary oil, which contains phytonutrients linked to hair growth and overall health benefits. He also suggested fermenting the treatment for up to 72 hours before use, which "enhances the quercetin" and increases the acidity, making it "very therapeutic for your scalp." Dr Berg recognised that this solution is not a 'miracle cure' and that alongside this, proper nutrition, including consuming enough vitamin D and a balanced diet, is essential for supporting hair health. Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club 4 4 4

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store